SILEXION THERAPEUTICS CORP Payments of Stock Issuance Costs
SILEXION THERAPEUTICS CORP (SLXN) reported Payments of Stock Issuance Costs of $118.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP payments of stock issuance costs for the quarter ending 2026-06-30 was $118.00K.
- SILEXION THERAPEUTICS CORP payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00.
- SILEXION THERAPEUTICS CORP payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $118.00K 10-Q · filed 2026-08-14 | $121.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 S-1/A · filed 2026-08-10 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | |||
| 2025-01-17 | $745.00K S-1/A · filed 2026-08-10 | ||||
| 2024-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $52.00K derived: sum of 2 quarters · filed 2026-08-10 | $52.00K S-1/A · filed 2026-08-10 | ||
| 2024-09-30 | $52.00K 10-Q · filed 2025-11-12 | $52.00K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | -$44.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $0.00 derived: sum of 2 quarters · filed 2025-08-20 | $3.00K derived: sum of 3 quarters · filed 2025-08-20 | $3.00K 8-K · filed 2025-08-20 | |
| 2023-09-30 | $44.00K 10-Q · filed 2024-11-14 | $47.00K derived: sum of 2 quarters · filed 2024-11-14 | $47.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-29 | $3.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |